Stock ATYR PHARMA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders aTyr Pharma Inc Nasdaq

Equities

US0021201035

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Insider Buy: aTYR Pharma
MT
ATyr Pharma, Inc. Advances Development of Lead Therapeutic Candidate ATYR1923 with Announcement of “efzofitimod” as Nonproprietary Name
CI
ATyr Pharma Announces the Appointment of Sara Zaknoen to its Board of Directors
CI
Insider Trends: Insider Buying Added to with Purchase of aTyr Pharma Shares
MT
ATyr Pharma Announces the Appointment of Andrea Wilson as A Patient Advisor
CI
Leading Cancer Researcher Dr. Judith Varner Joins aTyr Pharma as Scientific Advisor
CI
ATyr Pharma, Inc. Announces Resignation of James C. Blair as Director
CI
Arthur M. Mercurio Joins aTyr as Scientific Advisor
CI
Dr. David Briscoe Joins aTyr Pharma, Inc as Scientific Advisor
CI
ATyr Pharma, Inc. Announces Board Appointments
CI
ATyr Pharma, Inc. Announces Leadership Transition
CI
ATyr Pharma, Inc. Announces Executive Changes
CI
ATyr Pharma, Inc. Appoints Jill Broadfoot as Chief Financial Officer
CI
ATyr Pharma, Inc. Announces Srinivas Akkaraju Not to Stand for Re-Election as Director
CI
ATyr Pharma, Inc. Announces Retirement of Srinivas Akkaraju from the Board of Directors
CI
ATyr Pharma, Inc. Announces Executive Changes
CI
ATyr Pharma, Inc. Announces Resignation of John T. Blake as Senior Vice President, Finance and Principal Financial and Accounting Officer
CI
ATyr Pharma, Inc. Announces Executive Changes
CI
ATyr Pharma, Inc. Announces Management Changes
CI
ATyr Pharma, Inc. Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LIFE Stock
  4. Stock
  5. News aTyr Pharma Inc
  6. Insiders